402 related articles for article (PubMed ID: 36461054)
1. Determinants of cervical cancer screening service utilization among women attending healthcare services in Amhara region referral hospitals: a case-control study.
Legasu TD; Temesgen K; Ayele ZT; Chekole MS; Bayou FD; Fetene JC; Tibebu AT; Taye BT; Ali MA
BMC Womens Health; 2022 Dec; 22(1):484. PubMed ID: 36461054
[TBL] [Abstract][Full Text] [Related]
2. Risk factors of precancerous cervical lesions: The role of women's socio-demographic, sexual behavior and body mass index in Amhara region referral hospitals; case-control study.
Taye BT; Mihret MS; Muche HA
PLoS One; 2021; 16(3):e0249218. PubMed ID: 33770125
[TBL] [Abstract][Full Text] [Related]
3. Cervical cancer screening utilization and associated factors among women attending antenatal care at Asella Referral and Teaching Hospital, Arsi zone, South Central Ethiopia.
Shero AA; Kaso AW; Tafa M; Agero G; Abdeta G; Hailu A
BMC Womens Health; 2023 Apr; 23(1):199. PubMed ID: 37118809
[TBL] [Abstract][Full Text] [Related]
4. Factors affecting utilization of cervical cancer screening services among women attending public hospitals in Tigray region, Ethiopia, 2018; Case control study.
Teame H; Gebremariam L; Kahsay T; Berhe K; Gebreheat G; Gebremariam G
PLoS One; 2019; 14(3):e0213546. PubMed ID: 30870497
[TBL] [Abstract][Full Text] [Related]
5. Utilization of cervical cancer screening and associated factors among women in Debremarkos town, Amhara region, Northwest Ethiopia: Community based cross-sectional study.
Aynalem BY; Anteneh KT; Enyew MM
PLoS One; 2020; 15(4):e0231307. PubMed ID: 32255807
[TBL] [Abstract][Full Text] [Related]
6. Determinants of cervical cancer screening utilization among HIV-positive women, in public general hospitals of Central Zone, Tigray, Ethiopia, 2020: Case-control study.
Gebremeskel TG; Gebretatios MZ
PLoS One; 2023; 18(12):e0289042. PubMed ID: 38085714
[TBL] [Abstract][Full Text] [Related]
7. Cervical Cancer Screening Utilization and Associated Factors Among Women Aged 30 to 49 Years in Dire Dawa, Eastern Ethiopia.
Belay Y; Dheresa M; Sema A; Desalew A; Assefa N
Cancer Control; 2020; 27(1):1073274820958701. PubMed ID: 33034204
[TBL] [Abstract][Full Text] [Related]
8. Utilization and associated factors of cervical cancer screening service among eligible women attending maternal health services at Adare General Hospital, Hawassa city, Southern Ethiopia.
Assefa AA; Feleke T; G/Tsadik SA; Degela F; Zenebe A; Abera G
Sci Rep; 2024 Feb; 14(1):2774. PubMed ID: 38307895
[TBL] [Abstract][Full Text] [Related]
9. Knowledge, Attitude, and Practice Toward Cervical Cancer Screening Among Women Attending Health Facilities in Central Ethiopia.
Gebisa T; Bala ET; Deriba BS
Cancer Control; 2022; 29():10732748221076680. PubMed ID: 35315704
[TBL] [Abstract][Full Text] [Related]
10. HIV is still a major public health problem among pregnant women attending ANC in Referral Hospitals of the Amhara Regional State, Ethiopia: a cross sectional study.
Worku WZ; Azale T; Ayele TA; Mekonnen DK
BMC Womens Health; 2022 Nov; 22(1):468. PubMed ID: 36434557
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive knowledge on cervical cancer, attitude towards its screening and associated factors among women aged 30-49 years in Finote Selam town, northwest Ethiopia.
Geremew AB; Gelagay AA; Azale T
Reprod Health; 2018 Feb; 15(1):29. PubMed ID: 29444689
[TBL] [Abstract][Full Text] [Related]
12. Determinants of cervical cancer screening utilization among women attending health facilities of Dessie town, Northeast Ethiopia.
Assefa T; Arefaynie M; Mebratu W; Mohammed A; Addisu E; Kebede N
BMC Cancer; 2022 Dec; 22(1):1330. PubMed ID: 36539726
[TBL] [Abstract][Full Text] [Related]
13. Low uptake of cervical cancer screening among HIV positive women in Gondar University referral hospital, Northwest Ethiopia: cross-sectional study design.
Nega AD; Woldetsadik MA; Gelagay AA
BMC Womens Health; 2018 Jun; 18(1):87. PubMed ID: 29879969
[TBL] [Abstract][Full Text] [Related]
14. Cervical cancer screening service utilization and associated factors among HIV positive women attending adult ART clinic in public health facilities, Hawassa town, Ethiopia: a cross-sectional study.
Assefa AA; Astawesegn FH; Eshetu B
BMC Health Serv Res; 2019 Nov; 19(1):847. PubMed ID: 31744548
[TBL] [Abstract][Full Text] [Related]
15. Cervical cancer screening service utilization and associated factors among age-eligible women in Jimma town using health belief model, South West Ethiopia.
Nigussie T; Admassu B; Nigussie A
BMC Womens Health; 2019 Oct; 19(1):127. PubMed ID: 31660938
[TBL] [Abstract][Full Text] [Related]
16. Knowledge and practice of cervical cancer screening and associated factors among reproductive age group women in districts of Gurage zone, Southern Ethiopia. A cross-sectional study.
Endalew DA; Moti D; Mohammed N; Redi S; Wassihun Alemu B
PLoS One; 2020; 15(9):e0238869. PubMed ID: 32946461
[TBL] [Abstract][Full Text] [Related]
17. Determinants of long act reversible contraceptive utilization among HIV positive reproductive age women attending ART clinic in South West Ethiopia.
Kefeni BT; Tesfaye S; Bayisa K; Negara E; Bati F
Contracept Reprod Med; 2023 May; 8(1):30. PubMed ID: 37143084
[TBL] [Abstract][Full Text] [Related]
18. Determinants of hyperemesis gravidarum among pregnant women attending antenatal care at public and private hospitals in Bahir Dar City, North-West Ethiopia, 2022: a multicenter unmatched case control study.
Asrade L; Misikir D; Alemu H; Belachew A; Almaw H
BMC Womens Health; 2023 May; 23(1):225. PubMed ID: 37138281
[TBL] [Abstract][Full Text] [Related]
19. Predictors of cervical cancer screening service utilization among commercial sex workers in Northwest Ethiopia: a case-control study.
Muluneh BA; Atnafu DD; Wassie B
BMC Womens Health; 2019 Dec; 19(1):162. PubMed ID: 31842845
[TBL] [Abstract][Full Text] [Related]
20. Determinants of Cervical Cancer Screening Service Utilization Among HIV-Positive Women Aged 25 Years and Above Attending Adult ART Clinics in Southern Tigray, Ethiopia.
Gebrekirstos LG; Gebremedhin MH; Tafesse TT; Tura TS; Geleso MG; Wube TB
Cancer Control; 2022; 29():10732748221126944. PubMed ID: 36112936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]